Share this article
Share this article
ResearchAndMarkets.com s offering.
Amid the COVID-19 crisis, the global market for Antithrombin estimated at US$486.2 Million in the year 2020, is projected to reach a revised size of US$681 Million by 2027, growing at a CAGR of 4.9% over the analysis period 2020-2027.
Therapeutics, one of the segments analyzed in the report, is projected to record a 5% CAGR and reach US$640.1 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Research segment is readjusted to a revised 3.2% CAGR for the next 7-year period.
Germany
Australia
Japan
United-states
India
China
Canada
Dublin
Ireland
South-korea
Laura-wood
E-st-office-hours-call